Additional rounds of antiviral drug remdesivir distributed across Austin-area

Governor Greg Abbott has announced that the Texas Department of State Health Services (DSHS) is distributing six additional cases of the antiviral drug remdesivir to four hospitals across the Austin-area. The cases have been provided through the U.S. Department of Health and Human Services.

The exact hospitals were not listed in the news release from the governor's office but five cases were sent to Travis County and one case was sent to Williamson County.


Get breaking news alerts in the FOX 7 Austin News app. It is FREE!

Download for iOS or Android


DSHS will allocate 125 total cases of the liquid-form of remdesivir across Texas, enough to treat approximately 500 patients. This is the fourth round of distribution total from the federal government and will bring the total number of cases distributed by DSHS to Texas hospitals to 609.

RELATED: DSHS distributes additional cases of remdesivir in Austin, surrounding area

"By allocating additional cases of remdesivir to communities across the state, Texas is prioritizing the health and recovery of our fellow Texans," said Governor Abbott. "It is imperative that we continue to equip Texas medical providers with the supplies they need to respond to COVID-19, and I am grateful to our partners at the U.S. Department of Health and Human Services for their continued assistance in providing cases of remedisivir."

Officials say remdesivir has shown promise in early trials in speeding up the recovery time among hospitalized COVID-19 patients. The medication is being distributed by DSHS according to COVID-19 hospitalizations data to better target areas of need, which also includes state-owned hospitals.

Using a five-day average of hospitalization data from May 25th through May 29th, DSHS used county weighting of the number of COVID positive patients in hospitals to determine the number of remdesivir cases per county. The number of remdesivir cases each hospital will receive is allocated based on the hospitalized COVID positive patients in their hospital and county allocation.

RELATED: Abbott, Texas DSHS distribute antiviral drug in Austin to treat COVID-19

DSHS confirmed that military and VA hospitals will receive remdesivir directly and are therefore excluded from this distribution methodology. Additionally, because the use of limited supply is prioritized towards severely ill patients in facilities with ICUs, hospitals without ICU beds were excluded from the distribution. The liquid-form of remdesivir cannot be used for children, which also excludes children's hospitals from this distribution.

Medical staff at each hospital will determine how the drug will be used, though it must be prescribed in accordance with the Food and Drug Administration’s Emergency Use Authorization, allowing for the treatment of suspected or confirmed COVID-19 in adults and children hospitalized with severe diseases, such as those in intensive care.


Preliminary results from a clinical trial showed the average recovery time among patients who received remdesivir was 11 days versus 15 days with a placebo.

The supply is part of a donation from drug maker Gilead.